Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This quick overview presents the typical long-term return profile of total market funds, helping frame diversified retirement and growth goals.
28,588 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A single stock rally can expose ETF flaws. Learn how this chip ready micron moment reshapes EMG chip ETFs and what to...
Tuesday brought a notable wobble for the Nasdaq-100, leading the market’s tech retreat. This article breaks down the ...
Dell stock is on a rapid uptrend as profits beat expectations. This guide breaks down whether the rally can continue ...
Nvidia powers the AI era, but is its stock a smart buy right now? This guide breaks down the fundamentals, compares c...
As ad-tech rotates from pandemic-driven momentum to more measured growth, The Trade Desk faces a pivotal moment. This...
Poet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
Gas prices hover near fresh highs as families hit the road for the summer travel rush. A simple trio—drive slower, el...
This article breaks down the factors shaping JACK's Q2 2026 earnings, from menu pricing and digital growth to cost ma...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...